BackEncompass Health Overview
Encompass Health Corp

Encompass Health Target Price

See Encompass Health's analyst price targets ($150) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$120.97

Average Target Price

$149.7523.8% upside

4 analysts in the last 4 months

High: $155 | Low: $144

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-28Raymond JamesAndrew Cooper$15024% upsideOpen
2026-08-07Truist FinancialDavid MacDonald$15024% upsideOpen
2026-08-07UBS$15528.1% upsideOpen
2026-08-06Barclays$14419% upsideOpen
2026-05-22Leerink PartnersWhit Mayo$15225.7% upsideOpen
2026-05-05Barclays$14015.7% upsideOpen
2026-02-06Barclays$15326.5% upsideOpen
2025-10-30BarclaysAndrew Mok$15024% upsideOpen
2025-10-02UBS$15024% upsideOpen
2025-08-14Truist FinancialDavid MacDonald$14015.7% upsideOpen
2025-04-28RBC Capital$1253.3% upsideOpen
2024-09-26RBC CapitalBen Hendrix$10513.2% downsideOpen
2024-09-25UBSAJ Rice$1109.1% downsideOpen
2024-05-22RBC CapitalFrank Morgan$9521.5% downsideOpen
2024-04-25Mizuho SecuritiesAnn Hynes$9521.5% downsideOpen
2024-03-28BarclaysAndrew Mok$10116.5% downsideOpen
2022-05-03RBC Capital$8529.7% downsideOpen
2022-05-02Raymond James$8529.7% downsideOpen
2022-04-29Credit Suisse$8331.4% downsideOpen
2021-04-29StephensScott Fidel$10017.3% downsideOpen

Encompass Health (EHC) FAQ

Encompass Health's target price stands at $150. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $150 for EHC implies 23.8% upside versus today's price ($120.97). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Encompass Health's target price evolved across reporting periods, while the comparison chart places EHC next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Encompass Health's reading of $150 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.